Coronary Artery Bypass Grafting clinical trials

Explore recruiting coronary artery bypass grafting clinical trials.

Recruiting coronary artery bypass grafting studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coronary Artery Bypass Grafting trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparing high and lOw-dose asPirin with dual anTIplatelet therapy for three Months using prasUgrel and aSpirin following Coronary Artery Bypass Grafting. (OPTIMUS-CABG trial).

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial)

Finland, Iceland, Sweden, Denmark, Norway

Therapeutic use (Phase IV) EU CTIS Study details

Methadone versus fentanil and oxycodone for post-operative pain reduction in patients undergoing coronary artery bypass grafting and/or valve surgery – a placebo-controlled, double-blind, randomized clinical trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial on the Effects of EA-230 on the Length of Hospital Stay Following On-Pump Coronary Artery Bypass Grafting Surgery

Belgium, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery: Impact on Postoperative Cardiovascular Outcomes – DISCO Study

France

Therapeutic use (Phase IV) EU CTIS Study details

The RELEASE Trial: Reconsidering Long-Term Aspirin in the Elderly in Secondary Prevention of Cardiovascular Disease

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Coronary Artery Bypass Grafting trials by city

Coronary Artery Bypass Grafting in Toronto Coronary Artery Bypass Grafting in Vancouver Coronary Artery Bypass Grafting in Montreal Coronary Artery Bypass Grafting in Calgary Coronary Artery Bypass Grafting in Edmonton Coronary Artery Bypass Grafting in Ottawa Coronary Artery Bypass Grafting in Winnipeg Coronary Artery Bypass Grafting in Quebec City Coronary Artery Bypass Grafting in Hamilton Coronary Artery Bypass Grafting in Kitchener Coronary Artery Bypass Grafting in London Coronary Artery Bypass Grafting in Halifax Coronary Artery Bypass Grafting in New York Coronary Artery Bypass Grafting in Los Angeles Coronary Artery Bypass Grafting in Chicago Coronary Artery Bypass Grafting in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease